Melanie Cree
Concepts (387)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Polycystic Ovary Syndrome | 25 | 2024 | 141 | 13.630 |
Why?
| Insulin Resistance | 59 | 2024 | 1068 | 11.180 |
Why?
| Diabetes Mellitus, Type 2 | 31 | 2023 | 2088 | 4.450 |
Why?
| Obesity | 29 | 2024 | 2501 | 3.970 |
Why?
| Mitochondria, Muscle | 11 | 2024 | 90 | 3.900 |
Why?
| Blood Glucose | 37 | 2023 | 1823 | 3.640 |
Why?
| Pediatric Obesity | 11 | 2025 | 490 | 3.100 |
Why?
| Glucose Intolerance | 11 | 2021 | 136 | 2.940 |
Why?
| Muscle, Skeletal | 30 | 2024 | 1417 | 2.760 |
Why?
| Glucose Clamp Technique | 16 | 2023 | 181 | 2.690 |
Why?
| Insulin | 27 | 2024 | 2076 | 2.550 |
Why?
| Adolescent | 76 | 2025 | 17724 | 2.470 |
Why?
| Metformin | 10 | 2021 | 273 | 2.430 |
Why?
| Glucose Tolerance Test | 20 | 2023 | 338 | 2.310 |
Why?
| Testosterone | 7 | 2024 | 341 | 2.300 |
Why?
| Liver | 12 | 2023 | 1630 | 2.230 |
Why?
| Fasting | 7 | 2024 | 242 | 2.150 |
Why?
| Fatty Liver | 5 | 2024 | 209 | 2.130 |
Why?
| Triglycerides | 9 | 2022 | 464 | 2.030 |
Why?
| Hyperandrogenism | 3 | 2024 | 14 | 1.990 |
Why?
| Diabetes Mellitus, Type 1 | 17 | 2024 | 3252 | 1.750 |
Why?
| Fatty Acids, Nonesterified | 7 | 2018 | 150 | 1.670 |
Why?
| Metabolic Syndrome | 3 | 2020 | 317 | 1.640 |
Why?
| Female | 95 | 2025 | 59115 | 1.620 |
Why?
| Burns | 9 | 2010 | 232 | 1.590 |
Why?
| Body Mass Index | 11 | 2024 | 1952 | 1.470 |
Why?
| Lipid Metabolism | 6 | 2019 | 438 | 1.460 |
Why?
| Young Adult | 36 | 2025 | 10400 | 1.420 |
Why?
| Lipolysis | 4 | 2019 | 39 | 1.410 |
Why?
| Hyperinsulinism | 4 | 2019 | 103 | 1.360 |
Why?
| Child | 48 | 2024 | 18340 | 1.330 |
Why?
| Cross-Sectional Studies | 22 | 2024 | 4400 | 1.300 |
Why?
| Adipose Tissue | 6 | 2022 | 537 | 1.290 |
Why?
| Humans | 116 | 2025 | 113531 | 1.270 |
Why?
| Circadian Rhythm | 6 | 2025 | 347 | 1.240 |
Why?
| Magnetic Resonance Spectroscopy | 9 | 2024 | 472 | 1.240 |
Why?
| Oxidative Phosphorylation | 4 | 2019 | 154 | 1.190 |
Why?
| Glycerol | 6 | 2023 | 84 | 1.180 |
Why?
| Hypoglycemic Agents | 9 | 2019 | 1006 | 1.170 |
Why?
| Glucose | 10 | 2023 | 894 | 1.070 |
Why?
| Exercise | 12 | 2024 | 1617 | 1.020 |
Why?
| Insulin-Secreting Cells | 6 | 2020 | 317 | 1.020 |
Why?
| Case-Control Studies | 15 | 2024 | 2993 | 1.000 |
Why?
| Body Composition | 6 | 2024 | 584 | 0.990 |
Why?
| Male | 69 | 2025 | 55112 | 0.960 |
Why?
| Cardiovascular Diseases | 6 | 2019 | 1725 | 0.950 |
Why?
| Gastrointestinal Microbiome | 2 | 2021 | 498 | 0.910 |
Why?
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 118 | 0.880 |
Why?
| Androgens | 2 | 2022 | 166 | 0.860 |
Why?
| Prediabetic State | 4 | 2021 | 219 | 0.860 |
Why?
| Transition to Adult Care | 1 | 2024 | 60 | 0.840 |
Why?
| Adult | 42 | 2024 | 30245 | 0.830 |
Why?
| Hyperglycemia | 4 | 2021 | 292 | 0.820 |
Why?
| Non-alcoholic Fatty Liver Disease | 3 | 2021 | 244 | 0.790 |
Why?
| Adenosine Diphosphate | 2 | 2021 | 76 | 0.740 |
Why?
| Obesity, Morbid | 1 | 2024 | 197 | 0.730 |
Why?
| Overweight | 6 | 2025 | 473 | 0.730 |
Why?
| Klinefelter Syndrome | 1 | 2021 | 50 | 0.720 |
Why?
| Desogestrel | 1 | 2020 | 40 | 0.700 |
Why?
| Adolescent Medicine | 1 | 2020 | 33 | 0.690 |
Why?
| Lipogenesis | 2 | 2019 | 56 | 0.680 |
Why?
| Energy Metabolism | 3 | 2024 | 717 | 0.670 |
Why?
| Isotopes | 1 | 2019 | 27 | 0.670 |
Why?
| Endocrinology | 1 | 2020 | 71 | 0.650 |
Why?
| Inservice Training | 1 | 2020 | 106 | 0.650 |
Why?
| Sleep Disorders, Circadian Rhythm | 1 | 2019 | 36 | 0.640 |
Why?
| Absorptiometry, Photon | 6 | 2024 | 223 | 0.630 |
Why?
| Gluconeogenesis | 1 | 2019 | 60 | 0.630 |
Why?
| Sleep | 4 | 2025 | 568 | 0.630 |
Why?
| Mentors | 1 | 2020 | 155 | 0.620 |
Why?
| Obesity, Abdominal | 1 | 2018 | 37 | 0.610 |
Why?
| Mentoring | 1 | 2020 | 99 | 0.610 |
Why?
| Interprofessional Relations | 1 | 2020 | 246 | 0.600 |
Why?
| Adiposity | 4 | 2018 | 458 | 0.590 |
Why?
| Gynecology | 1 | 2020 | 163 | 0.590 |
Why?
| Fatty Acids | 2 | 2019 | 380 | 0.570 |
Why?
| Depressive Disorder | 1 | 2020 | 330 | 0.560 |
Why?
| Amino Acids | 3 | 2019 | 443 | 0.560 |
Why?
| Fenofibrate | 2 | 2007 | 24 | 0.560 |
Why?
| Oxygen Consumption | 9 | 2024 | 568 | 0.550 |
Why?
| Lipoproteins, HDL | 1 | 2017 | 74 | 0.550 |
Why?
| Biodiversity | 1 | 2020 | 347 | 0.550 |
Why?
| C-Peptide | 5 | 2019 | 138 | 0.540 |
Why?
| Hypolipidemic Agents | 2 | 2007 | 85 | 0.530 |
Why?
| Mitochondria | 5 | 2024 | 735 | 0.510 |
Why?
| Severity of Illness Index | 4 | 2025 | 2530 | 0.480 |
Why?
| Prognosis | 5 | 2020 | 3318 | 0.480 |
Why?
| Sleep Apnea, Obstructive | 2 | 2025 | 196 | 0.480 |
Why?
| Aging | 3 | 2019 | 1601 | 0.480 |
Why?
| Muscle Proteins | 7 | 2017 | 206 | 0.480 |
Why?
| Diabetes Mellitus | 2 | 2020 | 896 | 0.470 |
Why?
| Lipoproteins | 1 | 2015 | 157 | 0.460 |
Why?
| B-Lymphocytes | 1 | 2019 | 757 | 0.450 |
Why?
| Bacteria | 1 | 2020 | 716 | 0.450 |
Why?
| Decision Making | 1 | 2020 | 761 | 0.450 |
Why?
| Magnetic Resonance Imaging | 6 | 2024 | 3013 | 0.450 |
Why?
| Oxygen | 1 | 2018 | 827 | 0.440 |
Why?
| Follow-Up Studies | 6 | 2020 | 4384 | 0.430 |
Why?
| PPAR alpha | 3 | 2007 | 52 | 0.430 |
Why?
| Cardiorespiratory Fitness | 3 | 2024 | 35 | 0.420 |
Why?
| Risk Factors | 11 | 2021 | 8606 | 0.420 |
Why?
| Bed Rest | 2 | 2009 | 13 | 0.400 |
Why?
| Cohort Studies | 7 | 2021 | 4880 | 0.390 |
Why?
| Calorimetry, Indirect | 2 | 2024 | 65 | 0.380 |
Why?
| Insulin Glargine | 3 | 2019 | 72 | 0.380 |
Why?
| Cystic Fibrosis | 1 | 2020 | 953 | 0.370 |
Why?
| Puberty | 3 | 2024 | 131 | 0.370 |
Why?
| Hirsutism | 2 | 2021 | 10 | 0.340 |
Why?
| Retrospective Studies | 8 | 2024 | 12504 | 0.340 |
Why?
| Prospective Studies | 7 | 2020 | 6189 | 0.340 |
Why?
| Algorithms | 2 | 2021 | 1462 | 0.340 |
Why?
| Cushing Syndrome | 1 | 2009 | 10 | 0.340 |
Why?
| Gastroplasty | 2 | 2021 | 26 | 0.340 |
Why?
| Diabetic Nephropathies | 3 | 2020 | 234 | 0.330 |
Why?
| Estradiol | 3 | 2022 | 450 | 0.330 |
Why?
| Middle Aged | 14 | 2024 | 26552 | 0.330 |
Why?
| Sex Characteristics | 3 | 2025 | 633 | 0.290 |
Why?
| Exercise Tolerance | 4 | 2017 | 212 | 0.280 |
Why?
| Protein Kinase C | 1 | 2008 | 247 | 0.270 |
Why?
| Autoimmunity | 1 | 2012 | 813 | 0.260 |
Why?
| Diabetic Cardiomyopathies | 2 | 2016 | 33 | 0.260 |
Why?
| Actigraphy | 3 | 2025 | 75 | 0.260 |
Why?
| Reproducibility of Results | 8 | 2025 | 2752 | 0.250 |
Why?
| Melatonin | 3 | 2025 | 106 | 0.250 |
Why?
| Carnitine | 3 | 2019 | 62 | 0.240 |
Why?
| Biological Clocks | 1 | 2025 | 37 | 0.240 |
Why?
| Adiponectin | 2 | 2016 | 209 | 0.240 |
Why?
| Aged | 11 | 2020 | 18944 | 0.240 |
Why?
| Polysomnography | 1 | 2025 | 135 | 0.230 |
Why?
| Lipoproteins, VLDL | 1 | 2024 | 21 | 0.230 |
Why?
| Age Factors | 3 | 2020 | 2875 | 0.230 |
Why?
| Adenosine Triphosphate | 2 | 2021 | 426 | 0.230 |
Why?
| Alanine Transaminase | 1 | 2024 | 140 | 0.220 |
Why?
| Basal Metabolism | 1 | 2024 | 44 | 0.220 |
Why?
| Lipids | 4 | 2017 | 558 | 0.220 |
Why?
| Leg | 5 | 2021 | 218 | 0.220 |
Why?
| Muscle Contraction | 3 | 2014 | 386 | 0.220 |
Why?
| Colorado | 5 | 2020 | 4061 | 0.210 |
Why?
| Endocrine System Diseases | 1 | 2023 | 30 | 0.210 |
Why?
| Vascular Stiffness | 2 | 2019 | 403 | 0.210 |
Why?
| Time Factors | 6 | 2025 | 6032 | 0.210 |
Why?
| Muscle Strength | 2 | 2017 | 270 | 0.210 |
Why?
| Biomarkers | 6 | 2019 | 3389 | 0.210 |
Why?
| Gonadotropin-Releasing Hormone | 1 | 2024 | 189 | 0.210 |
Why?
| Sleep Deprivation | 1 | 2025 | 157 | 0.210 |
Why?
| Sex Factors | 3 | 2017 | 1705 | 0.200 |
Why?
| Double-Blind Method | 3 | 2019 | 1643 | 0.200 |
Why?
| Saliva | 2 | 2025 | 187 | 0.200 |
Why?
| Carbon Isotopes | 4 | 2019 | 110 | 0.200 |
Why?
| Tandem Mass Spectrometry | 1 | 2024 | 405 | 0.200 |
Why?
| Sleep Wake Disorders | 2 | 2019 | 223 | 0.200 |
Why?
| Transgender Persons | 1 | 2024 | 134 | 0.200 |
Why?
| Phosphocreatine | 1 | 2021 | 36 | 0.190 |
Why?
| Glutathione | 1 | 2023 | 291 | 0.190 |
Why?
| Child, Preschool | 8 | 2022 | 9093 | 0.190 |
Why?
| Alopecia | 1 | 2021 | 28 | 0.180 |
Why?
| Bacteroidetes | 1 | 2021 | 20 | 0.180 |
Why?
| Body Weight | 2 | 2019 | 853 | 0.180 |
Why?
| Protein Biosynthesis | 2 | 2017 | 375 | 0.180 |
Why?
| Firmicutes | 1 | 2021 | 17 | 0.180 |
Why?
| Contraceptive Devices, Female | 1 | 2020 | 9 | 0.180 |
Why?
| Ovarian Reserve | 1 | 2020 | 13 | 0.170 |
Why?
| United States | 3 | 2021 | 12137 | 0.170 |
Why?
| Sex Chromosome Disorders of Sex Development | 1 | 2020 | 9 | 0.170 |
Why?
| Drug Implants | 1 | 2020 | 70 | 0.170 |
Why?
| Carotid Intima-Media Thickness | 2 | 2018 | 65 | 0.170 |
Why?
| Primary Ovarian Insufficiency | 1 | 2020 | 30 | 0.170 |
Why?
| Physicians, Women | 1 | 2020 | 55 | 0.170 |
Why?
| Glucose Metabolism Disorders | 1 | 2019 | 10 | 0.170 |
Why?
| Arginine | 2 | 2019 | 235 | 0.160 |
Why?
| Prednisolone | 1 | 2019 | 75 | 0.160 |
Why?
| Aorta | 2 | 2019 | 377 | 0.160 |
Why?
| Device Removal | 1 | 2020 | 122 | 0.160 |
Why?
| Liraglutide | 1 | 2019 | 27 | 0.160 |
Why?
| Predictive Value of Tests | 1 | 2024 | 1783 | 0.160 |
Why?
| Sitagliptin Phosphate | 1 | 2019 | 29 | 0.160 |
Why?
| Amino Acids, Essential | 2 | 2009 | 12 | 0.160 |
Why?
| Adrenocorticotropic Hormone | 1 | 2019 | 124 | 0.160 |
Why?
| Uromodulin | 1 | 2019 | 21 | 0.160 |
Why?
| Waist Circumference | 1 | 2019 | 120 | 0.160 |
Why?
| Virilism | 1 | 2019 | 5 | 0.160 |
Why?
| Menstruation Disturbances | 1 | 2019 | 12 | 0.160 |
Why?
| Sex Hormone-Binding Globulin | 1 | 2019 | 48 | 0.160 |
Why?
| Contraceptives, Oral | 1 | 2019 | 23 | 0.160 |
Why?
| Withholding Treatment | 1 | 2019 | 66 | 0.160 |
Why?
| Diastole | 1 | 2019 | 135 | 0.160 |
Why?
| Peer Group | 1 | 2020 | 199 | 0.160 |
Why?
| Respiratory Function Tests | 1 | 2020 | 517 | 0.160 |
Why?
| Spironolactone | 1 | 2019 | 27 | 0.160 |
Why?
| Erythrocytes | 1 | 2023 | 566 | 0.160 |
Why?
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 42 | 0.160 |
Why?
| Wakefulness | 1 | 2019 | 101 | 0.150 |
Why?
| RNA, Ribosomal, 16S | 1 | 2021 | 479 | 0.150 |
Why?
| Minority Groups | 1 | 2020 | 225 | 0.150 |
Why?
| Feces | 1 | 2021 | 369 | 0.150 |
Why?
| Deuterium | 3 | 2015 | 79 | 0.150 |
Why?
| Career Choice | 1 | 2020 | 177 | 0.150 |
Why?
| Intra-Abdominal Fat | 1 | 2018 | 77 | 0.150 |
Why?
| Psychiatric Status Rating Scales | 1 | 2020 | 483 | 0.150 |
Why?
| Cell Respiration | 1 | 2018 | 71 | 0.150 |
Why?
| Cardiotonic Agents | 1 | 2018 | 123 | 0.150 |
Why?
| Universities | 1 | 2020 | 337 | 0.150 |
Why?
| Kidney | 4 | 2021 | 1179 | 0.150 |
Why?
| Spasms, Infantile | 1 | 2019 | 103 | 0.150 |
Why?
| Incidence | 2 | 2021 | 2310 | 0.150 |
Why?
| Social Media | 1 | 2020 | 130 | 0.150 |
Why?
| Occupational Exposure | 1 | 2020 | 254 | 0.140 |
Why?
| Phosphorus Isotopes | 1 | 2017 | 7 | 0.140 |
Why?
| Hindlimb | 1 | 2017 | 123 | 0.140 |
Why?
| Blood Vessels | 1 | 2018 | 179 | 0.140 |
Why?
| Child Behavior | 1 | 2019 | 217 | 0.140 |
Why?
| Affect | 1 | 2019 | 245 | 0.140 |
Why?
| Prevalence | 2 | 2021 | 2244 | 0.140 |
Why?
| Parenting | 1 | 2020 | 252 | 0.140 |
Why?
| Societies, Medical | 1 | 2020 | 654 | 0.130 |
Why?
| Social Support | 1 | 2020 | 534 | 0.130 |
Why?
| Human Development | 1 | 2016 | 14 | 0.130 |
Why?
| Regional Blood Flow | 2 | 2016 | 407 | 0.130 |
Why?
| Hospitals, Pediatric | 2 | 2017 | 480 | 0.130 |
Why?
| Bone Density | 1 | 2020 | 432 | 0.130 |
Why?
| Placental Insufficiency | 1 | 2017 | 102 | 0.130 |
Why?
| Estrogens | 1 | 2019 | 311 | 0.130 |
Why?
| Metabolome | 1 | 2019 | 275 | 0.130 |
Why?
| Leptin | 1 | 2017 | 207 | 0.130 |
Why?
| Milk Proteins | 2 | 2006 | 35 | 0.130 |
Why?
| Schools | 1 | 2018 | 393 | 0.120 |
Why?
| Glucocorticoids | 1 | 2019 | 520 | 0.120 |
Why?
| Drug Therapy, Combination | 1 | 2018 | 944 | 0.120 |
Why?
| Pneumonia, Viral | 1 | 2020 | 333 | 0.120 |
Why?
| Coronavirus Infections | 1 | 2020 | 325 | 0.120 |
Why?
| Life Style | 2 | 2018 | 427 | 0.120 |
Why?
| Pulse Wave Analysis | 3 | 2021 | 206 | 0.120 |
Why?
| Exercise Therapy | 1 | 2018 | 351 | 0.110 |
Why?
| Glomerular Filtration Rate | 4 | 2020 | 605 | 0.110 |
Why?
| Metabolomics | 1 | 2019 | 508 | 0.110 |
Why?
| Surveys and Questionnaires | 2 | 2020 | 4593 | 0.110 |
Why?
| Phosphorus | 1 | 2014 | 81 | 0.110 |
Why?
| Biopsy | 2 | 2008 | 1024 | 0.110 |
Why?
| Inflammation Mediators | 1 | 2017 | 469 | 0.110 |
Why?
| Blood Pressure | 2 | 2017 | 1521 | 0.110 |
Why?
| Echocardiography | 1 | 2016 | 563 | 0.110 |
Why?
| Ventricular Function, Left | 1 | 2016 | 469 | 0.100 |
Why?
| Fetal Growth Retardation | 1 | 2017 | 470 | 0.100 |
Why?
| Models, Biological | 1 | 2019 | 1589 | 0.100 |
Why?
| Area Under Curve | 3 | 2008 | 271 | 0.100 |
Why?
| Emotions | 1 | 2017 | 474 | 0.100 |
Why?
| Physicians | 1 | 2020 | 765 | 0.100 |
Why?
| Pandemics | 1 | 2020 | 1308 | 0.100 |
Why?
| Models, Theoretical | 1 | 2015 | 505 | 0.100 |
Why?
| Regression Analysis | 2 | 2025 | 932 | 0.100 |
Why?
| Pyruvic Acid | 2 | 2010 | 41 | 0.100 |
Why?
| Disease Progression | 2 | 2022 | 2364 | 0.100 |
Why?
| Hypoglycemia | 1 | 2016 | 386 | 0.100 |
Why?
| Hypertension | 1 | 2019 | 1051 | 0.100 |
Why?
| Linear Models | 2 | 2014 | 767 | 0.100 |
Why?
| Treatment Outcome | 6 | 2019 | 9006 | 0.090 |
Why?
| Creatinine | 3 | 2020 | 434 | 0.090 |
Why?
| Internship and Residency | 1 | 2020 | 920 | 0.090 |
Why?
| Jet Lag Syndrome | 1 | 2019 | 7 | 0.080 |
Why?
| Acyl Coenzyme A | 2 | 2006 | 29 | 0.080 |
Why?
| Quality Improvement | 1 | 2016 | 951 | 0.080 |
Why?
| Sensitivity and Specificity | 2 | 2025 | 1682 | 0.080 |
Why?
| Diabetes, Gestational | 1 | 2012 | 281 | 0.080 |
Why?
| Hypertriglyceridemia | 1 | 2008 | 33 | 0.080 |
Why?
| Palmitates | 1 | 2008 | 16 | 0.080 |
Why?
| Protein Kinase C beta | 1 | 2008 | 22 | 0.080 |
Why?
| Spectrometry, Mass, Electrospray Ionization | 2 | 2005 | 160 | 0.080 |
Why?
| Risk Assessment | 1 | 2017 | 2953 | 0.070 |
Why?
| Longitudinal Studies | 2 | 2024 | 2361 | 0.070 |
Why?
| Hospitalization | 1 | 2016 | 1765 | 0.070 |
Why?
| Muscle Cells | 1 | 2007 | 41 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 2 | 2005 | 463 | 0.070 |
Why?
| Albuminuria | 2 | 2020 | 164 | 0.070 |
Why?
| Acetates | 1 | 2007 | 91 | 0.070 |
Why?
| Animals | 8 | 2017 | 31162 | 0.070 |
Why?
| Trauma Severity Indices | 1 | 2007 | 108 | 0.070 |
Why?
| Islets of Langerhans | 1 | 2012 | 728 | 0.070 |
Why?
| Critical Care | 1 | 2010 | 474 | 0.060 |
Why?
| Phenylalanine | 4 | 2009 | 57 | 0.060 |
Why?
| Carbon Dioxide | 1 | 2007 | 205 | 0.060 |
Why?
| Muscular Atrophy | 1 | 2006 | 74 | 0.060 |
Why?
| Self Report | 1 | 2019 | 696 | 0.060 |
Why?
| Oxidation-Reduction | 1 | 2008 | 912 | 0.060 |
Why?
| Milk | 1 | 2006 | 123 | 0.060 |
Why?
| Caseins | 1 | 2004 | 18 | 0.060 |
Why?
| Cystatin C | 2 | 2014 | 62 | 0.060 |
Why?
| Albumins | 1 | 2005 | 88 | 0.060 |
Why?
| Fibrinogen | 1 | 2005 | 142 | 0.060 |
Why?
| Physical Exertion | 1 | 2005 | 200 | 0.050 |
Why?
| Mitochondrial Diseases | 1 | 2024 | 76 | 0.050 |
Why?
| Stress, Physiological | 1 | 2006 | 375 | 0.050 |
Why?
| Placebos | 2 | 2019 | 198 | 0.050 |
Why?
| Glycolysis | 1 | 2024 | 223 | 0.050 |
Why?
| Exercise Test | 3 | 2016 | 546 | 0.050 |
Why?
| Dietary Carbohydrates | 1 | 2003 | 137 | 0.050 |
Why?
| Light | 1 | 2025 | 331 | 0.050 |
Why?
| Critical Illness | 1 | 2007 | 653 | 0.050 |
Why?
| Culture Media, Conditioned | 1 | 2022 | 103 | 0.050 |
Why?
| Pregnancy | 3 | 2020 | 5490 | 0.050 |
Why?
| Gonadotropins | 1 | 2020 | 37 | 0.040 |
Why?
| Hydroxyestrones | 1 | 2000 | 2 | 0.040 |
Why?
| Isoflavones | 1 | 2000 | 16 | 0.040 |
Why?
| Chromosomes, Human, X | 1 | 2020 | 61 | 0.040 |
Why?
| Sex Chromosome Aberrations | 1 | 2020 | 51 | 0.040 |
Why?
| Anti-Mullerian Hormone | 1 | 2020 | 50 | 0.040 |
Why?
| Parental Leave | 1 | 2020 | 17 | 0.040 |
Why?
| Trisomy | 1 | 2020 | 68 | 0.040 |
Why?
| Salaries and Fringe Benefits | 1 | 2020 | 51 | 0.040 |
Why?
| Practice Guidelines as Topic | 2 | 2017 | 1378 | 0.040 |
Why?
| Causality | 1 | 2019 | 105 | 0.040 |
Why?
| Administration, Oral | 3 | 2006 | 719 | 0.040 |
Why?
| Sulfonylurea Compounds | 1 | 2019 | 44 | 0.040 |
Why?
| Hormones | 1 | 2019 | 132 | 0.040 |
Why?
| Rats, Zucker | 2 | 2010 | 27 | 0.040 |
Why?
| Biological Transport | 2 | 2010 | 363 | 0.040 |
Why?
| Diabetic Angiopathies | 1 | 2019 | 246 | 0.030 |
Why?
| Magnetic Resonance Angiography | 1 | 2018 | 218 | 0.030 |
Why?
| Infant, Newborn | 2 | 2020 | 5032 | 0.030 |
Why?
| Whey Proteins | 2 | 2006 | 5 | 0.030 |
Why?
| Physicians, Primary Care | 1 | 2018 | 222 | 0.030 |
Why?
| Tertiary Care Centers | 1 | 2016 | 127 | 0.030 |
Why?
| Echocardiography, Doppler | 1 | 2016 | 94 | 0.030 |
Why?
| Infant | 2 | 2019 | 7922 | 0.030 |
Why?
| Sheep | 1 | 2017 | 760 | 0.030 |
Why?
| Comorbidity | 1 | 2019 | 1443 | 0.030 |
Why?
| Oxidative Stress | 1 | 2021 | 1065 | 0.030 |
Why?
| Diagnosis, Differential | 1 | 2018 | 1328 | 0.030 |
Why?
| Rabbits | 2 | 2005 | 713 | 0.030 |
Why?
| Mothers | 1 | 2020 | 651 | 0.030 |
Why?
| Stress, Mechanical | 1 | 2016 | 441 | 0.030 |
Why?
| Weight Loss | 1 | 2018 | 640 | 0.030 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 126 | 0.030 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2014 | 181 | 0.030 |
Why?
| Biomechanical Phenomena | 1 | 2016 | 664 | 0.030 |
Why?
| Cholesterol, LDL | 1 | 2014 | 306 | 0.030 |
Why?
| Diet | 1 | 2000 | 1076 | 0.030 |
Why?
| Glucagon | 1 | 2012 | 92 | 0.020 |
Why?
| Parents | 1 | 2020 | 1175 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2014 | 1421 | 0.020 |
Why?
| Malonyl Coenzyme A | 1 | 2010 | 5 | 0.020 |
Why?
| Rats | 2 | 2010 | 4829 | 0.020 |
Why?
| Adaptation, Physiological | 1 | 2014 | 465 | 0.020 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2010 | 33 | 0.020 |
Why?
| Glycogen | 1 | 2010 | 50 | 0.020 |
Why?
| Sciatic Nerve | 1 | 2010 | 56 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2010 | 368 | 0.020 |
Why?
| Cholesterol, VLDL | 1 | 2008 | 4 | 0.020 |
Why?
| Primary Health Care | 1 | 2018 | 1502 | 0.020 |
Why?
| Clinical Protocols | 1 | 2010 | 231 | 0.020 |
Why?
| Lactic Acid | 1 | 2010 | 269 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 783 | 0.020 |
Why?
| Drug Administration Schedule | 1 | 2010 | 712 | 0.020 |
Why?
| Radioactive Tracers | 1 | 2007 | 3 | 0.020 |
Why?
| Citric Acid Cycle | 1 | 2007 | 42 | 0.020 |
Why?
| Sodium Bicarbonate | 1 | 2007 | 40 | 0.020 |
Why?
| Breath Tests | 1 | 2007 | 81 | 0.020 |
Why?
| Cholesterol | 1 | 2008 | 365 | 0.020 |
Why?
| Multienzyme Complexes | 1 | 2006 | 63 | 0.020 |
Why?
| Diglycerides | 1 | 2006 | 52 | 0.020 |
Why?
| Palmitoylcarnitine | 1 | 2005 | 1 | 0.020 |
Why?
| Methods | 1 | 2005 | 56 | 0.020 |
Why?
| Carbohydrate Sequence | 1 | 2005 | 23 | 0.020 |
Why?
| Palmitic Acid | 1 | 2005 | 37 | 0.020 |
Why?
| AMP-Activated Protein Kinases | 1 | 2006 | 170 | 0.020 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2006 | 262 | 0.020 |
Why?
| Reference Standards | 1 | 2005 | 160 | 0.020 |
Why?
| Dietary Supplements | 1 | 2008 | 459 | 0.020 |
Why?
| Metabolic Clearance Rate | 1 | 2005 | 103 | 0.010 |
Why?
| Weight Lifting | 1 | 2004 | 29 | 0.010 |
Why?
| Phenotype | 1 | 2012 | 2754 | 0.010 |
Why?
| Hydrocortisone | 1 | 2006 | 267 | 0.010 |
Why?
| Patient Discharge | 1 | 2010 | 770 | 0.010 |
Why?
| Leucine | 1 | 2004 | 102 | 0.010 |
Why?
| Fluorocarbons | 1 | 2005 | 94 | 0.010 |
Why?
| Chromatography, Liquid | 1 | 2005 | 339 | 0.010 |
Why?
| Heart Rate | 1 | 2007 | 705 | 0.010 |
Why?
| Analysis of Variance | 1 | 2006 | 1208 | 0.010 |
Why?
| Blood Proteins | 1 | 2005 | 217 | 0.010 |
Why?
| Phosphorylation | 1 | 2006 | 1537 | 0.010 |
Why?
| Motor Activity | 1 | 2006 | 623 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 2005 | 1956 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2005 | 2741 | 0.010 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2000 | 38 | 0.010 |
Why?
| Premenopause | 1 | 2000 | 105 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2005 | 2293 | 0.010 |
Why?
| Signal Transduction | 1 | 2006 | 4439 | 0.010 |
Why?
| Breast Neoplasms | 1 | 2000 | 1842 | 0.000 |
Why?
|
|
Cree's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|